Full text
Earnings transcript
Read the complete earnings call transcript.
UHS
Universal Health Services, Inc.
$146.59
3.72
(2.6%)
| Exchange: | NYSE |
| Market Cap: | 9.177B |
| Shares Outstanding: | 140M |
Delayed data
About The Company
| Sector: | Healthcare | |||||
| Industry: | Medical – Care Facilities | |||||
| CEO: | Marc D. Miller | |||||
| Full Time Employees: | 78400 | |||||
| Address: |
| |||||
| Website: | https://uhs.com |
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company’s significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 14,281,976 | 15,827,935 | 17,364,829 |
| Gross Profit | 12,749,148 | 14,240,149 | 15,705,820 |
| EBITDA | 1,715,141 | 2,265,280 | 2,743,141 |
| Operating Income | 1,175,381 | 1,681,814 | 1,994,015 |
| Net Income | 717,795 | 1,142,097 | 1,488,796 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 13,967,602 | 14,469,749 | 15,527,593 |
| Total Liabilities | 7,765,696 | 7,706,933 | 8,188,805 |
| Total Stockholders Equity | 6,149,001 | 6,666,207 | 7,338,788 |
| Total Debt | 5,366,628 | 4,955,429 | 5,166,503 |
| Cash and Cash Equivalents | 119,439 | 125,983 | 137,797 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 1,267,797 | 2,067,101 | 1,864,397 |
| Capital Expenditure | -743,055 | -943,810 | -1,015,152 |
| Free Cash Flow | 524,742 | 1,123,291 | 849,245 |
| Net Income | 717,487 | 1,163,109 | 1,511,182 |
| Net Change in Cash | 13,633 | 10,282 | 46,570 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2029 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 20,451,511.604 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 21,266,258.433 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 20,976,400 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 2,821,584.774 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 2,933,991.001 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 2,894,000.796 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 1,872,199.547 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 1,969,911.693 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 1,935,149.270 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 10,133,243.028 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 10,536,930.921 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 10,393,312.884 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 30.020 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 30.560 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 29.040 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 4 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 2 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Robust Revenue Growth: UHS has demonstrated consistent revenue increases in recent income statements, reflecting strong operational performance. This growth aligns with industry trends in the healthcare sector, supported by rising demand for medical services as indicated in sector performance metrics (sector_perf1y, sector_perf5y).
- Solid Profitability Metrics: Key metrics such as gross profit margin (grossProfitMarginTTM) and net profit margin (netProfitMarginTTM) indicate efficient cost management and profitability, positioning UHS favorably against industry averages (industry_avg_priceToEarningsRatioTTM).
- Strong Cash Flow Generation: Positive free cash flow (freeCashFlowYieldTTM) and operating cash flow trends from cash flow statements highlight UHS's ability to fund operations and investments internally, reducing reliance on external financing.
Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates UHS intrinsic value between $243.44 – $263.87 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about UHS valuation
Is Universal Health Services, Inc. (UHS) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Universal Health Services, Inc. (UHS) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is UHS a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether UHS trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is UHS’s P/E ratio?
You can see UHS’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for UHS?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is UHS a good long-term investment?
Whether UHS fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
UHS
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
2.6
Trading Metrics:
| Open: | 143.27 | Previous Close: | 142.87 | |
| Day Low: | 141.74 | Day High: | 146.75 | |
| Year Low: | 140.08 | Year High: | 246.33 | |
| Price Avg 50: | 168.87 | Price Avg 200: | 199.34 | |
| Volume: | 993454 | Average Volume: | 926084 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeUHS full analysis
Welcome to MARKETSNAP’s SWOT analysis for Universal Health Services, or UHS as you might know it on the ticker. If you’re not familiar with this name, let me give you the quick rundown. Universal Health Services is a major player in the healthcare sector, specifically in the hospital and healthcare facilities industry. Based in the United States, they operate a wide network of hospitals, behavioral health centers, and ambulatory care facilities. With thousands of full-time employees under their belt, they’re…
